SAR-397769

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameSAR-397769

Drug Alias NameSAR-397769

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTyrosine-protein kinase SRC inhibitorsYes tyrosine protein kinase inhibitorsVascular endothelial growth factor receptor 2 antagonists

TargetsTyrosine-protein kinase SRCYes tyrosine protein kinaseVascular endothelial growth factor receptor 2

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A